Bluejay Diagnostics, Inc. (BJDX) Insider Trading Disclosures
Bluejay Diagnostics, Inc. (BJDX) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BJDX
CIK: 1704287
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Wolf & Company, P.C.
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerDerek Thomas
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-13 | 2026-10-13 | CURRENT REPORT | 0001213900-26-108779 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-06 | CURRENT REPORT | 0001213900-26-106999 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-01 | CURRENT REPORT | 0001213900-26-098071 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001127 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001126 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001125 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001124 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-17 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001123292-26-001123 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001172661-26-003556 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001493152-26-037644 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | CURRENT REPORT | 0001213900-26-088701 | View SEC Doc Filr Page |
| S-8 | 2026-08-12 | — | REGISTRATION STATEMENT | 0001213900-26-088412 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-088347 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-21 | CURRENT REPORT | 0001213900-26-080474 | View SEC Doc Filr Page |
| 4 | 2026-07-22 | 2026-07-21 | PRIMARY DOCUMENT | 0000070858-26-000359 | View SEC Doc Filr Page |
| 3 | 2026-07-22 | 2026-07-20 | PRIMARY DOCUMENT | 0000070858-26-000358 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-09 | PRIMARY DOCUMENT | 0001475597-26-000158 | View SEC Doc Filr Page |
| 3 | 2026-07-13 | 2026-07-09 | PRIMARY DOCUMENT | 0001475597-26-000157 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | PRIMARY DOCUMENT | 0000070858-26-000349 | View SEC Doc Filr Page |
| 3 | 2026-07-10 | 2026-07-07 | PRIMARY DOCUMENT | 0000070858-26-000348 | View SEC Doc Filr Page |
| EFFECT | 2026-06-26 | — | EFFECT Filing | 9999999995-26-002139 | View SEC Doc Filr Page |
| 424B3 | 2026-06-26 | — | PROSPECTUS | 0001213900-26-072672 | View SEC Doc Filr Page |
| S-3 | 2026-06-17 | — | REGISTRATION STATEMENT | 0001213900-26-069727 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-09 | CURRENT REPORT | 0001213900-26-066896 | View SEC Doc Filr Page |
| 8-K | 2026-06-08 | 2026-06-02 | CURRENT REPORT | 0001213900-26-066364 | View SEC Doc Filr Page |